Nordic Luveris Study
Recombinant LH Supplementation to Recombinant FSH During the Final Days of Controlled Ovarian Stimulation for IVF: a Multicentre, Prospective, Randomized, Controlled Trial
Lead SponsorUniversity of Copenhagen
StatusCompleted No Results Posted
Indication/ConditionInfertility In Vitro Fertilization
Intervention/Treatmentfollitropin alfa lutropin alpha ...
To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
75 iu/day form cycle day 6
rFSH 150 iu/day
rFSH + rLH arm
Inclusion Criteria: Age below 40 Infertility treatable by IVF or ICSI Regular cycles Exclusion Criteria: NA